NASDAQ:PIII P3 Health Partners (PIII) Stock Price, News & Analysis $9.62 +0.31 (+3.33%) Closing price 07/24/2026 04:00 PM EasternExtended Trading$9.74 +0.12 (+1.20%) As of 07/24/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock About P3 Health Partners Stock (NASDAQ:PIII) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get P3 Health Partners alerts:Sign Up Key Stats Today's Range$9.12▼$9.9350-Day Range$9.17▼$16.4752-Week Range$1.52▼$16.89Volume18,101 shsAverage Volume25,981 shsMarket Capitalization$69.65 millionP/E RatioN/ADividend YieldN/APrice Target$14.00Consensus RatingHold Company Overview P3 Health Partners is a healthcare technology and services company that delivers data-driven solutions to support health plans in improving quality measures, risk adjustment accuracy and operational efficiency. The company’s platform integrates advanced analytics, reporting capabilities and workflow automation to help clients optimize performance across value-based care programs and regulatory requirements. The company’s core offerings include quality measurement and reporting for HEDIS, STAR and other performance frameworks, risk adjustment coding and audit services, and population health analytics. By combining proprietary software with professional services teams, P3 Health Partners assists payers in identifying gaps in care, enhancing member engagement and ensuring compliance with state and federal guidelines. Its solutions encompass data ingestion, normalization, predictive modeling and targeted outreach strategies designed to drive measurable improvements in clinical and financial outcomes. Headquartered in Dallas, Texas, P3 Health Partners serves a broad base of commercial, Medicare Advantage and Medicaid health plans across the United States. The company is led by a management team with deep expertise in healthcare analytics, payer operations and quality improvement initiatives. Through strategic partnerships and ongoing investment in its technology platform, P3 Health Partners aims to help clients navigate the evolving healthcare landscape and deliver more cost-effective, member-centric care.AI Generated. May Contain Errors. Read More P3 Health Partners Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks52nd Percentile Overall ScorePIII MarketRank™: P3 Health Partners scored higher than 52% of companies evaluated by MarketBeat, and ranked 525th out of 836 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingHold Consensus RatingP3 Health Partners has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 2 hold ratings, and 1 sell rating.Upside PotentialP3 Health Partners has a consensus price target of $14.00, representing about 45.5% upside from its current price of $9.62.Amount of Analyst CoverageP3 Health Partners has only been the subject of 3 research reports in the past 90 days.Read more about P3 Health Partners' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of P3 Health Partners is -0.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of P3 Health Partners is -0.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about P3 Health Partners' valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.59% of the float of P3 Health Partners has been sold short.Short Interest Ratio / Days to CoverP3 Health Partners has a short interest ratio ("days to cover") of 1.26, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in P3 Health Partners has recently decreased by 21.58%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldP3 Health Partners does not currently pay a dividend.Dividend GrowthP3 Health Partners does not have a long track record of dividend growth. News and Social Media1.8 / 5News Sentiment0.94 News SentimentP3 Health Partners has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for P3 Health Partners this week, compared to 2 articles on an average week. Company Ownership0.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, P3 Health Partners insiders have not sold or bought any company stock.Percentage Held by Insiders10.86% of the stock of P3 Health Partners is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions7.75% of the stock of P3 Health Partners is held by institutions.Read more about P3 Health Partners' insider trading history. Receive PIII Stock News and Ratings via Email Sign-up to receive the latest news and ratings for P3 Health Partners and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PIII Stock News HeadlinesP3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference CallJuly 21, 2026 | businesswire.comContrasting Enovis (NYSE:ENOV) and P3 Health Partners (NASDAQ:PIII)July 17, 2026 | americanbankingnews.comAI billionaires are selling. Quickly.Nvidia CEO Jensen Huang has logged 42 consecutive sell transactions - not a single buy. Peter Thiel liquidated his entire Nvidia position. SoftBank dumped $5.8 billion. And Michael Burry, who famously predicted the housing crash, is now betting against AI stocks. But 40-year investment veteran Alexander Green says the insiders are only half right - and that the biggest AI profits may still be ahead, potentially 10X larger, just not from where most investors are looking.July 26 at 1:00 AM | The Oxford Club (Ad)P3 Health Partners (PIII) Stock Sees Fair Value Lift After Strong EBITDA And GuidanceJune 27, 2026 | finance.yahoo.comPIII Share News TodayJune 22, 2026 | uk.investing.comP3 Health Partners Stockholders Back Board, Warrants ProposalJune 10, 2026 | tipranks.comP3 Health Partners Regains Full Nasdaq Listing ComplianceMay 26, 2026 | tipranks.comWhat's going on with P3 Health Partners stock Monday?May 18, 2026 | msn.comSee More Headlines PIII Stock Analysis - Frequently Asked Questions How have PIII shares performed this year? P3 Health Partners' stock was trading at $3.49 at the beginning of the year. Since then, PIII shares have increased by 175.6% and is now trading at $9.62. How were P3 Health Partners' earnings last quarter? P3 Health Partners Inc. (NASDAQ:PIII) released its quarterly earnings results on Thursday, May, 14th. The company reported $0.32 EPS for the quarter, beating the consensus estimate of ($4.85) by $5.17. The business had revenue of $386.39 million for the quarter, compared to the consensus estimate of $391.45 million. Read the conference call transcript. When did P3 Health Partners' stock split? P3 Health Partners's stock reverse split on the morning of Monday, April 14th 2025.The 1-50 reverse split was announced on Friday, April 4th 2025. The number of shares owned by shareholders was adjusted after the market closes on Friday, April 11th 2025. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. How do I buy shares of P3 Health Partners? Shares of PIII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of P3 Health Partners own? Based on aggregate information from My MarketBeat watchlists, some other companies that P3 Health Partners investors own include Avino Silver & Gold Mines (ASM), PayPal (PYPL), TriNet Group (TNET), Taiwan Semiconductor Manufacturing (TSM), XPENG (XPEV), 3M (MMM) and nCino (NCNO). Company Calendar Last Earnings5/14/2026Today7/26/2026Next Earnings (Confirmed)8/10/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (4m+) 1-Year History Jul 25 Oct 25 Jan 26 Apr 26 Jul 26 PIII's financial health is in the Green zone, according to TradeSmith. PIII has been in this zone for over 4 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MEDICAL INFO SYS Sub-IndustryHealthcare Current SymbolNASDAQ:PIII CIK1832511 Webforesightacq.com Phone702-910-3950FaxN/AEmployees500Year FoundedN/APrice Target and Rating Average Price Target for P3 Health Partners$14.00 High Price Target$14.00 Low Price Target$14.00 Potential Upside/Downside+45.5%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)($38.60) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$147.95 million Net Margins-8.57% Pretax Margin-19.42% Return on EquityN/A Return on Assets-19.99% Debt Debt-to-Equity RatioN/A Current Ratio0.33 Quick Ratio0.33 Sales & Book Value Annual Sales$1.46 billion Price / Sales0.05 Cash FlowN/A Price / Cash FlowN/A Book Value($21.55) per share Price / Book-0.45Miscellaneous Outstanding Shares7,240,000Free Float6,458,000Market Cap$69.65 million OptionableNot Optionable Beta1.62 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (NASDAQ:PIII) was last updated on 7/26/2026 by MarketBeat.com Staff. From Our PartnersThe comeback story of the century (ticker inside)In 2013, this struggling PC maker went private amid skepticism from Forbes and the New York Times. Instead of ...InvestorPlace | SponsoredUniversal basic income is not impossible. It exist (kind of)Robert Kiyosaki, author of Rich Dad Poor Dad, is highlighting an income strategy he calls the Patriot Income P...Freedom Financial | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredThis tiny piece of glass could be bigger than GPUsJensen Huang says AI can't scale without it. Google Ventures calls it the future of AI compute. Sequoia Capita...Brownstone Research | SponsoredOxford Club Analyst’s Urgent AI WarningAlexander Green, Chief Investment Strategist at The Oxford Club, is sharing a private presentation with a warn...The Oxford Club | SponsoredTrump’s New Currency ResetTrump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...Porter & Company | SponsoredThe 90%-off options that empty accountsA call that cost $3.00 last month now trades for $0.30 - a 90% discount that looks tempting. It's not a bar...Profits Run | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding P3 Health Partners Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share P3 Health Partners With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
